California SB1094 mandates that health insurance policies and health care service plans include biosimilar or interchangeable biological products on.
California SB1094 amends the Business and Professions Code and the Insurance Code to ensure that health insurance policies and health care service plans include biosimilar or interchangeable biological products on their formularies if they have a lower net cost than the reference product. The bill requires insurers and plans to notify prescribers and enrollees about biosimilar substitutions and provides conditions under which a pharmacist may substitute a biosimilar or interchangeable biological product for a prescribed reference product.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.